These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5163461)

  • 1. [Inconvenience of the cessation of pain of leprosy patients].
    Egea Bueno L
    Actas Dermosifiliogr; 1971; 62(7):347-9. PubMed ID: 5163461
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG vaccination. Comparative study of the lepromin response (Mitsuda-test) to the oral and intradermal routes of administration of the vaccine.
    Azulay RD; Kahn H; Scorzelli A; Meyerheim R
    Int J Lepr Other Mycobact Dis; 1971; 39(2):508-21. PubMed ID: 5169811
    [No Abstract]   [Full Text] [Related]  

  • 3. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline tuberculoid leprosy following BCG vaccination. A case report.
    Stoner GL; Belehu A; Nsibambi J; Warndorff J
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):16-20. PubMed ID: 7195879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG vaccination.
    Ironside AG
    Practitioner; 1971 Apr; 206(234):488-93. PubMed ID: 5576887
    [No Abstract]   [Full Text] [Related]  

  • 6. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG vaccine-associated suppurative lymphadenitis.
    Teo SS; Smeulders N; Shingadia DV
    Vaccine; 2005 Apr; 23(20):2676-9. PubMed ID: 15780451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG vaccination protects against leprosy in Venezuela: a case-control study.
    Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to the study of leprosy and BCG vaccination among the children of lepers and non-family contacts in Iran].
    Assefi V; Gaulier M; Gaulier A
    Acta Leprol; 1984; 2(1):39-45. PubMed ID: 6385599
    [No Abstract]   [Full Text] [Related]  

  • 13. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the story of Bacillus Calmette Guerin (BCG) vaccine in prevention of leprosy.
    Zodpey SP
    Indian J Public Health; 2006; 50(2):67-9. PubMed ID: 17191407
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
    Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective efficacy of BCG against leprosy in São Paulo, Brazil].
    Lombardi C; Pedrazzani ES; Pedrazzani JC; Ferreira Filho P; Zicker F
    Bol Oficina Sanit Panam; 1995 Nov; 119(5):415-21. PubMed ID: 8540997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG vaccination against leprosy.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(2):186-90. PubMed ID: 5950071
    [No Abstract]   [Full Text] [Related]  

  • 18. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
    Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology of skin reactions to BCG].
    Thiel M
    Pathologe; 1981 Mar; 2(2):97-102. PubMed ID: 7232332
    [No Abstract]   [Full Text] [Related]  

  • 20. Value of BCG in the prophylaxis of leprosy.
    Jonquières ED
    Int J Lepr Other Mycobact Dis; 1967; 35(1):76-8. PubMed ID: 6067039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.